Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Enterprise Value: 2019-2025

Historic Enterprise Value for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $545.6 million.

  • Eton Pharmaceuticals' Enterprise Value rose 304.90% to $545.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $487.9 million, marking a year-over-year increase of 517.43%. This contributed to the annual value of $329.2 million for FY2024, which is 261.78% up from last year.
  • Eton Pharmaceuticals' Enterprise Value amounted to $545.6 million in Q3 2025, which was up 52.93% from $356.8 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Enterprise Value registered a high of $545.6 million during Q3 2025, and its lowest value of $39.7 million during Q3 2022.
  • Moreover, its 3-year median value for Enterprise Value was $91.0 million (2023), whereas its average is $197.3 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Enterprise Value plummeted by 60.82% in 2022 and then soared by 433.86% in 2025.
  • Quarterly analysis of 5 years shows Eton Pharmaceuticals' Enterprise Value stood at $91.2 million in 2021, then plummeted by 39.63% to $55.0 million in 2022, then surged by 65.35% to $91.0 million in 2023, then surged by 261.78% to $329.2 million in 2024, then skyrocketed by 304.90% to $545.6 million in 2025.
  • Its last three reported values are $545.6 million in Q3 2025, $356.8 million for Q2 2025, and $330.7 million during Q1 2025.